Article ; Online: Amelioration of mild and moderate depression through Pranic Healing as adjuvant therapy: randomised double-blind controlled trial.
Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists
2017 Volume 26, Issue 1, Page(s) 82–87
Abstract: Objectives: Depression is a mental disorder, affecting the quality of life. Our study explores the efficacy of Pranic Healing (PH), as an adjuvant therapy in treating depression Methods: In this randomised double-blind controlled trial, 52 participants ... ...
| Abstract | Objectives: Depression is a mental disorder, affecting the quality of life. Our study explores the efficacy of Pranic Healing (PH), as an adjuvant therapy in treating depression Methods: In this randomised double-blind controlled trial, 52 participants with a mean age of 34.4 years, with mild to moderate depression were assessed using the Hamilton Depression Rating (HAM-D) scale during the 5-week study. Both Medication + PH (MedPH) and Medication + Mock PH (MedMockPH) groups comprising 26 members received Pranic and mock healing lasting 20 minutes per session respectively once a week for 4 weeks, along with the antidepressant drug. Results: The average decrease in HAM-D score in MedPH was median 11 (Interquartile Range (IQR) 7-12) and was significantly higher compared with the MedMockPH group median 6.5 (IQR 3-9). At pre-assessment, both groups had 8 cases of mild and 18 cases of moderate depression. At post-assessment, HAM-D showed that the improvement in depression category was seen in 69.2% of participants in the MedMockPH group and 100% in MedPH group. Conclusions: These results give first the evidence that PH can aid as an adjuvant therapy for depressed people. |
|---|---|
| MeSH term(s) | Adult ; Citalopram/pharmacology ; Combined Modality Therapy ; Depression/drug therapy ; Depression/therapy ; Depressive Disorder/drug therapy ; Depressive Disorder/therapy ; Double-Blind Method ; Female ; Humans ; Male ; Medicine, Ayurvedic ; Middle Aged ; Mind-Body Therapies/methods ; Outcome Assessment (Health Care) ; Serotonin Uptake Inhibitors/administration & dosage ; Serotonin Uptake Inhibitors/pharmacology ; Severity of Illness Index |
| Chemical Substances | Serotonin Uptake Inhibitors ; Citalopram (0DHU5B8D6V) |
| Language | English |
| Publishing date | 2017-08-24 |
| Publishing country | England |
| Document type | Journal Article ; Randomized Controlled Trial |
| ZDB-ID | 2213198-X |
| ISSN | 1440-1665 ; 1039-8562 |
| ISSN (online) | 1440-1665 |
| ISSN | 1039-8562 |
| DOI | 10.1177/1039856217726449 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 6220: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
|||
| Zs.MO 581: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.